Myrobalan Therapeutics

Myrobalan Therapeutics, a Massachusetts-based biotech firm, has successfully completed a $24 million Series A funding round, featuring significant participation from Chinese investors. The financing was led by Shenzhen-based Co-win Ventures, with contributions from both new and existing investors, including Guan Zi Equity Investment (Li Shui) Partnership, 3E Bioventures Capital, and…